Cargando…
Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction
INTRODUCTION: Patients who survive acute kidney injury (AKI) may receive fewer cardioprotective drugs. Our objective was to measure the difference in time to dispensing of evidence-based cardiovascular drugs in patients with a history of myocardial infarction (MI) with and without AKI. METHODS: This...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939314/ https://www.ncbi.nlm.nih.gov/pubmed/36815105 http://dx.doi.org/10.1016/j.ekir.2022.10.027 |
_version_ | 1784890819739648000 |
---|---|
author | Meraz-Muñoz, Alejandro Y. Jeyakumar, Nivethika Luo, Bin Beaubien-Souligny, William Chanchlani, Rahul Clark, Edward G. Harel, Ziv Kitchlu, Abhijat Neyra, Javier A. Zappitelli, Michael Chertow, Glenn M. Garg, Amit X. Wald, Ron Silver, Samuel A. |
author_facet | Meraz-Muñoz, Alejandro Y. Jeyakumar, Nivethika Luo, Bin Beaubien-Souligny, William Chanchlani, Rahul Clark, Edward G. Harel, Ziv Kitchlu, Abhijat Neyra, Javier A. Zappitelli, Michael Chertow, Glenn M. Garg, Amit X. Wald, Ron Silver, Samuel A. |
author_sort | Meraz-Muñoz, Alejandro Y. |
collection | PubMed |
description | INTRODUCTION: Patients who survive acute kidney injury (AKI) may receive fewer cardioprotective drugs. Our objective was to measure the difference in time to dispensing of evidence-based cardiovascular drugs in patients with a history of myocardial infarction (MI) with and without AKI. METHODS: This was a population-based cohort study of patients 66 years of age and older with a history of MI who survived a hospitalization complicated with AKI, propensity-score matched to patients without AKI. The primary outcome was time to outpatient dispensing of an angiotensin-converting enzyme inhibitor (ACEi)/angiotensin II receptor blocker (ARB), statin, or β-blocker within 1 year of hospital discharge. RESULTS: We identified 28,871 patients with AKI, of whom 21,452 were matched 1:1 to patients without AKI. In the matched cohort, mean age was 80 years, 40% were female, and 34% had an MI during the index hospitalization. AKI was associated with less frequent dispensing of all 3 cardiovascular drug classes within 1 year of hospital discharge (subdistribution hazard ratio [sHR], 0.93; 95% confidence interval [CI], 0.91–0.95). This association was most pronounced in patients with stage 2 (sHR, 0.81; 95% CI, 0.75–0.88) and stage 3 (sHR, 0.71; 95% CI, 0.64–0.79) AKI. We observed less frequent dispensing of statins in patients with stage 2 (sHR, 0.87; 95% CI, 0.81–0.92) and stage 3 (sHR, 0.85; 95% CI, 0.78–0.93) AKI and less frequent dispensing of β-blockers in patients with stage 3 AKI (sHR, 0.86; 95% CI, 0.79–0.94). CONCLUSION: In patients with a history of MI, survivors of AKI were less likely to receive prescriptions for ACEi/ARB, statins, or β-blockers within 1 year of hospital discharge. This association was most pronounced in patients with stages 2 and 3 AKI. |
format | Online Article Text |
id | pubmed-9939314 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-99393142023-02-21 Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction Meraz-Muñoz, Alejandro Y. Jeyakumar, Nivethika Luo, Bin Beaubien-Souligny, William Chanchlani, Rahul Clark, Edward G. Harel, Ziv Kitchlu, Abhijat Neyra, Javier A. Zappitelli, Michael Chertow, Glenn M. Garg, Amit X. Wald, Ron Silver, Samuel A. Kidney Int Rep Clinical Research INTRODUCTION: Patients who survive acute kidney injury (AKI) may receive fewer cardioprotective drugs. Our objective was to measure the difference in time to dispensing of evidence-based cardiovascular drugs in patients with a history of myocardial infarction (MI) with and without AKI. METHODS: This was a population-based cohort study of patients 66 years of age and older with a history of MI who survived a hospitalization complicated with AKI, propensity-score matched to patients without AKI. The primary outcome was time to outpatient dispensing of an angiotensin-converting enzyme inhibitor (ACEi)/angiotensin II receptor blocker (ARB), statin, or β-blocker within 1 year of hospital discharge. RESULTS: We identified 28,871 patients with AKI, of whom 21,452 were matched 1:1 to patients without AKI. In the matched cohort, mean age was 80 years, 40% were female, and 34% had an MI during the index hospitalization. AKI was associated with less frequent dispensing of all 3 cardiovascular drug classes within 1 year of hospital discharge (subdistribution hazard ratio [sHR], 0.93; 95% confidence interval [CI], 0.91–0.95). This association was most pronounced in patients with stage 2 (sHR, 0.81; 95% CI, 0.75–0.88) and stage 3 (sHR, 0.71; 95% CI, 0.64–0.79) AKI. We observed less frequent dispensing of statins in patients with stage 2 (sHR, 0.87; 95% CI, 0.81–0.92) and stage 3 (sHR, 0.85; 95% CI, 0.78–0.93) AKI and less frequent dispensing of β-blockers in patients with stage 3 AKI (sHR, 0.86; 95% CI, 0.79–0.94). CONCLUSION: In patients with a history of MI, survivors of AKI were less likely to receive prescriptions for ACEi/ARB, statins, or β-blockers within 1 year of hospital discharge. This association was most pronounced in patients with stages 2 and 3 AKI. Elsevier 2022-11-02 /pmc/articles/PMC9939314/ /pubmed/36815105 http://dx.doi.org/10.1016/j.ekir.2022.10.027 Text en © 2022 Published by Elsevier Inc. on behalf of the International Society of Nephrology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Clinical Research Meraz-Muñoz, Alejandro Y. Jeyakumar, Nivethika Luo, Bin Beaubien-Souligny, William Chanchlani, Rahul Clark, Edward G. Harel, Ziv Kitchlu, Abhijat Neyra, Javier A. Zappitelli, Michael Chertow, Glenn M. Garg, Amit X. Wald, Ron Silver, Samuel A. Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction |
title | Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction |
title_full | Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction |
title_fullStr | Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction |
title_full_unstemmed | Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction |
title_short | Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction |
title_sort | cardiovascular drug use after acute kidney injury among hospitalized patients with a history of myocardial infarction |
topic | Clinical Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939314/ https://www.ncbi.nlm.nih.gov/pubmed/36815105 http://dx.doi.org/10.1016/j.ekir.2022.10.027 |
work_keys_str_mv | AT merazmunozalejandroy cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT jeyakumarnivethika cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT luobin cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT beaubiensoulignywilliam cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT chanchlanirahul cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT clarkedwardg cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT harelziv cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT kitchluabhijat cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT neyrajaviera cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT zappitellimichael cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT chertowglennm cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT gargamitx cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT waldron cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction AT silversamuela cardiovasculardruguseafteracutekidneyinjuryamonghospitalizedpatientswithahistoryofmyocardialinfarction |